Immunogenicity and efficacy of intradermal tattoo immunization with adenoviral vector vaccinesPOTTHOFF, A; SCHWANNECKE, S; NABI, G et al.Vaccine. 2009, Vol 27, Num 21, pp 2768-2774, issn 0264-410X, 7 p.Article

Improved influenza vaccination in the skin using vaccine coated microneedlesKIM, Yeu-Chun; QUAN, Fu-Shi; YOO, Dae-Goon et al.Vaccine. 2009, Vol 27, Num 49, pp 6932-6938, issn 0264-410X, 7 p.Article

Improved antibody responses in infants less than 1 year old using intradermal influenza vaccinationSUGIMURA, Tetsu; ITO, Yuhei; TANANARI, Yoshifumi et al.Vaccine. 2008, Vol 26, Num 22, pp 2700-2705, issn 0264-410X, 6 p.Article

New emerging technologies and the intradermal route: the novel way to immunize against influenzaFALSEY, Ann R.Vaccine. Supplement. 2010, Vol 28, Num 4, issn 1359-5938, D24-D32Article

Protection and immune response in pigs intradermally vaccinated against porcine reproductive and respiratory syndrome (PRRS) and subsequently exposed to a heterologous European (Italian cluster) field strainMARTELLI, Paolo; CORDIOLI, Paolo; ALBORALI, Loris Giovanni et al.Vaccine. 2007, Vol 25, Num 17, pp 3400-3408, issn 0264-410X, 9 p.Article

Immunogenicity and safety of low dose virosomal adjuvanted influenza vaccine administered intradermally compared to intramuscular full dose administrationKÜNZI, Valérie; KLAP, Jaco M; SEIBERLING, Michael K et al.Vaccine. 2009, Vol 27, Num 27, pp 3561-3567, issn 0264-410X, 7 p.Article

Des nouveaux vaccins aux nouvelles cibles: le vaccin grippe revisité = From new vaccine to new target: revisiting Influenza vaccinationGERARD, M.Revue médicale de Bruxelles. 2011, Vol 32, Num 4, pp 280-283, issn 0035-3639, 4 p.Conference Paper

A phase I evaluation of inactivated influenza A/H5N1 vaccine administered by the intradermal or the intramuscular routePATEL, Shital M; ATMAR, Robert L; EL SAHLY, Hana M et al.Vaccine. 2010, Vol 28, Num 17, pp 3025-3029, issn 0264-410X, 5 p.Article

Simulated post-exposure rabies vaccination with purified chick embryo cell vaccine using a modified Thai Red Cross regimenMADHUSUDANA, S. N; SANJAY, T. V; MAHENDRA, B. J et al.International journal of infectious diseases. 2004, Vol 8, Num 3, pp 175-179, issn 1201-9712, 5 p.Article

Efficacy of intradermally administrated E2 subunit vaccines in reducing horizontal transmission of classical swine fever virusDORTMANS, J. C. F. M; LOEFFEN, W. L. A; WEERDMEESTER, K et al.Vaccine. 2008, Vol 26, Num 9, pp 1235-1242, issn 0264-410X, 8 p.Article

Co-encapsulation of antigen and Toll-like receptor ligand in cationic liposomes affects the quality of the immune response in mice after intradermal vaccinationBAL, Suzanne M; HORTENSIUS, Sander; ZHI DING et al.Vaccine. 2011, Vol 29, Num 5, pp 1045-1052, issn 0264-410X, 8 p.Article

The mast cell activator compound 48/80 is safe and effective when used as an adjuvant for intradermal immunization with Bacillus anthracis protective antigenMCGOWEN, Afton L; HALE, Laura P; SHELBURNE, Christopher P et al.Vaccine. 2009, Vol 27, Num 27, pp 3544-3552, issn 0264-410X, 9 p.Article

Evaluation of cell-mediated immune responses to two BCG vaccination regimes in young children in South KoreaLE, Hyejon; SANG NAE CHO; DOCKRELL, Hazel M et al.Vaccine. 2011, Vol 29, Num 38, pp 6564-6571, issn 0264-410X, 8 p.Article

Adjuvanted, antigen loaded N-trimethyl chitosan nanoparticles for nasal and intradermal vaccination: Adjuvant- and site-dependent immunogenicity in miceBAL, Suzanne M; SLÜTTER, Bram; VERHEUL, Rolf et al.European journal of pharmaceutical sciences. 2012, Vol 45, Num 4, pp 475-481, issn 0928-0987, 7 p.Conference Paper

Comparison of intramuscular and intradermal applications of hepatitis B vaccine in hemodialysis patientsKARAHOCAGIL, M. Kasim; BUZGAN, Turan; IRMAK, Hasan et al.Renal failure. 2006, Vol 28, Num 7, pp 561-565, issn 0886-022X, 5 p.Article